{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:43:01Z","timestamp":1784241781825,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.metabol.2022.155219","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:11:49Z","timestamp":1652872309000},"page":"155219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Epitranscriptomic challenges and promises in metabolic diseases"],"prefix":"10.1016","volume":"132","author":[{"given":"Despina","family":"Sanoudou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi K.","family":"Gkouskou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristides G.","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155219_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5339\/gcsp.2012.7","article-title":"The expanding role of epigenetics","volume":"2012","author":"Kalozoumi","year":"2012","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.metabol.2022.155219_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101296","article-title":"Emerging roles of epigenetic regulation in obesity and metabolic disease","volume":"297","author":"Park","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2022.155219_bb0015","article-title":"The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","volume":"111S","author":"Perakakis","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155219_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154461","article-title":"Advances in biological therapies for dyslipidemias and atherosclerosis","volume":"116","author":"Valanti","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155219_bb0025","series-title":"RNA modification database","author":"Modomics","year":"2022"},{"key":"10.1016\/j.metabol.2022.155219_bb0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.molmed.2018.07.010","article-title":"Epitranscriptomic code and its alterations in human disease","volume":"24","author":"Kadumuri","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2022.155219_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx1030","article-title":"MODOMICS: a database of RNA modification pathways. 2017 update","volume":"46","author":"Boccaletto","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.metabol.2022.155219_bb0040","doi-asserted-by":"crossref","first-page":"D195","DOI":"10.1093\/nar\/gkq1028","article-title":"The RNA modification database, RNAMDB: 2011 update","volume":"39","author":"Cantara","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41580-021-00342-0","article-title":"The expanding world of tRNA modifications and their disease relevance","volume":"22","author":"Suzuki","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2022.155219_bb0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tibs.2021.02.002","article-title":"ADAR RNA modifications, the epitranscriptome and innate immunity","volume":"46","author":"Quin","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.metabol.2022.155219_bb0055","article-title":"Epitranscriptomics of cardiovascular diseases (Review)","volume":"49","author":"Leptidis","year":"2022","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.metabol.2022.155219_bb0060","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1261\/rna.063503.117","article-title":"The RNA modification landscape in human disease","volume":"23","author":"Jonkhout","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.metabol.2022.155219_bb0065","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.drudis.2021.06.004","article-title":"m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options","volume":"26","author":"Garbo","year":"2021","journal-title":"Drug Discov Today"},{"issue":"Suppl 1","key":"10.1016\/j.metabol.2022.155219_bb0070","article-title":"Mitochondrial diabetes: molecular mechanisms and clinical presentation","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155219_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-5491.2008.02359.x","article-title":"Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation","volume":"25","author":"Murphy","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2022.155219_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.23196","article-title":"Matchmaking facilitates the diagnosis of an autosomal-recessive mitochondrial disease caused by biallelic mutation of the tRNA isopentenyltransferase (TRIT1) gene","volume":"38","author":"Kernohan","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2022.155219_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003888","article-title":"tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans","volume":"9","author":"Igoillo-Esteve","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2022.155219_bb0090","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1172\/JCI58056","article-title":"Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice","volume":"121","author":"Wei","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2022.155219_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s42255-019-0089-9","article-title":"m(6)A mRNA methylation regulates human beta-cell biology in physiological states and in type 2 diabetes","volume":"1","author":"De Jesus","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2022.155219_bb0100","article-title":"M6A mRNA methylation regulates the innate immune response in human \u00df-cells","volume":"70","author":"De Jesus DFZ","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155219_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","article-title":"m(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7","volume":"16","author":"Wang","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.metabol.2022.155219_bb0110","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41467-020-15488-2","article-title":"METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2022.155219_bb0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2022.155219_bb0120","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1096\/fj.201802644R","article-title":"METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1\/STAT5\/C\/EBPbeta pathway via an m(6)A-YTHDF2-dependent manner","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2022.155219_bb0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2015.03.006","article-title":"IGF2BP2\/IMP2-deficient mice resist obesity through enhanced translation of Ucp1 mRNA and other mRNAs encoding mitochondrial proteins","volume":"21","author":"Dai","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155219_bb0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gutjnl-2013-305736","article-title":"The insulin-like growth factor 2 (IGF2) mRNA-binding protein p62\/IGF2BP2-2 as a promoter of NAFLD and HCC?","volume":"63","author":"Simon","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155219_bb0135","doi-asserted-by":"crossref","first-page":"G328","DOI":"10.1152\/ajpgi.00005.2012","article-title":"IGF2 mRNA binding protein p62\/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2\/PI3K signaling","volume":"304","author":"Kessler","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2022.155219_bb0140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.metabol.2022.155219_bb0145","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12942","article-title":"Emerging role of m(6) a RNA methylation in nutritional physiology and metabolism","volume":"21","author":"Wu","year":"2020","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2022.155219_bb0155","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.metabol.2022.155219_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.702579","article-title":"Changes in N6-methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy","volume":"9","author":"Ju","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2022.155219_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108616","article-title":"The potential role of m6A RNA methylation in diabetic retinopathy","volume":"208","author":"Kumari","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtn.2020.02.002","article-title":"N(6)-methyladenosine METTL3 modulates the proliferation and apoptosis of lens epithelial cells in diabetic cataract","volume":"20","author":"Yang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.metabol.2022.155219_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/genes11080907","article-title":"Extracurricular functions of tRNA modifications in microorganisms","volume":"11","author":"Edwards","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.metabol.2022.155219_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.780617","article-title":"Analysis of N6-methyladenosine methylation modification in fructose-induced non-alcoholic fatty liver disease","volume":"12","author":"Luo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2022.155219_bb0185","article-title":"Long-term impact of maternal dietary intervention on metabolic homeostasis in male offspring in mice","volume":"108971","author":"Ueno","year":"2022","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.metabol.2022.155219_bb0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N(6)-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.metabol.2022.155219_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biochi.2019.07.008","article-title":"Nutrigenomics and RNA methylation: role of micronutrients","volume":"164","author":"Mosca","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2022.155219_bb0200","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1021\/acsomega.9b02236","article-title":"Resveratrol and curcumin improve intestinal mucosal integrity and decrease m(6)A RNA methylation in the intestine of weaning piglets","volume":"4","author":"Gan","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.metabol.2022.155219_bb0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lipd.12023","article-title":"Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m(6) a RNA methylation in piglets","volume":"53","author":"Lu","year":"2018","journal-title":"Lipids"},{"key":"10.1016\/j.metabol.2022.155219_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/14.4.551","article-title":"Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency","volume":"14","author":"Christman","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2022.155219_bb0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature25460","article-title":"Mitochondrial translation requires folate-dependent tRNA methylation","volume":"554","author":"Morscher","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155219_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.744171","article-title":"Dynamic m(6)A mRNA methylation reveals the role of METTL3\/14-m(6)A-MNK2-ERK signaling Axis in skeletal muscle differentiation and regeneration","volume":"9","author":"Xie","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2022.155219_bb0225","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1210\/en.2006-0640","article-title":"Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease","volume":"147","author":"Anway","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2022.155219_bb0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.envres.2019.05.011","article-title":"Exposure to environmental toxicants reduces global N6-methyladenosine RNA methylation and alters expression of RNA methylation modulator genes","volume":"175","author":"Cayir","year":"2019","journal-title":"Environ Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.772243","article-title":"Genetically-guided medical nutrition therapy in type 2 diabetes mellitus and pre-diabetes: a series of n-of-1 superiority trials","volume":"9","author":"Gkouskou","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.metabol.2022.155219_bb0240","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/advances\/nmaa089","article-title":"The \"virtual digital twins\" concept in precision nutrition","volume":"11","author":"Gkouskou","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/j.metabol.2022.155219_bb0245","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1172\/JCI44403","article-title":"A link between FTO, ghrelin, and impaired brain food-cue responsivity","volume":"123","author":"Karra","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2022.155219_bb0250","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrendo.2013.155","article-title":"Metabolism: FTO-associated obesity risk is linked to brain food responses via modulation of ghrelin levels","volume":"9","author":"Eissing","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2022.155219_bb0255","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3945\/ajcn.113.082164","article-title":"FTO genotype, dietary protein, and change in appetite: the preventing overweight using novel dietary strategies trial","volume":"99","author":"Huang","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2022.155219_bb0260","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1502214","article-title":"FTO obesity variant circuitry and adipocyte Browning in humans","volume":"373","author":"Claussnitzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155219_bb0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41422-018-0127-2","article-title":"Transcriptome-wide reprogramming of N(6)-methyladenosine modification by the mouse microbiome","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0270","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41467-020-15126-x","article-title":"Impact of the gut microbiota on the m(6)A epitranscriptome of mouse cecum and liver","volume":"11","author":"Jabs","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2022.155219_bb0275","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2022.155219_bb0280","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"issue":"283\u201392","key":"10.1016\/j.metabol.2022.155219_bb0285","article-title":"Mettl14 is essential for epitranscriptomic regulation of striatal function and learning","volume":"99","author":"Koranda","year":"2018","journal-title":"Neuron"},{"issue":"389\u2013403","key":"10.1016\/j.metabol.2022.155219_bb0290","article-title":"The role of m(6)A\/m-RNA methylation in stress response regulation","volume":"99","author":"Engel","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.metabol.2022.155219_bb0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"issue":"1816\u201328","key":"10.1016\/j.metabol.2022.155219_bb0300","article-title":"Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation","volume":"25","author":"Zhong","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2022.155219_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051464","article-title":"Maternal protein restriction in rats alters the expression of genes involved in mitochondrial metabolism and epitranscriptomics in fetal hypothalamus","volume":"12","author":"Frapin","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2022.155219_bb0310","doi-asserted-by":"crossref","first-page":"18193","DOI":"10.1038\/srep18193","article-title":"RNA-mediated paternal heredity of diet-induced obesity and metabolic disorders","volume":"5","author":"Grandjean","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2022.155219_bb0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.aad7977","article-title":"Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic disorder","volume":"351","author":"Chen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.metabol.2022.155219_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2022.155219_bb0325","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2022.155219_bb0330","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1021\/ja3064149","article-title":"Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor","volume":"134","author":"Chen","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.metabol.2022.155219_bb0335","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-015-0420-1","article-title":"FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice","volume":"71","author":"Chen","year":"2015","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.metabol.2022.155219_bb0340","article-title":"RNA modifications as emerging therapeutic targets.","author":"Cayir","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.metabol.2022.155219_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/genes12030345","article-title":"The regulation of RNA modification systems: the next frontier in epitranscriptomics?","volume":"12","author":"Schaefer","year":"2021","journal-title":"Genes (Basel)"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952200097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952200097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:35Z","timestamp":1758429035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952200097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":69,"alternative-id":["S002604952200097X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155219","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitranscriptomic challenges and promises in metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155219"}}